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Abstract: We propose a new filter based feature selection algorithm for classification based on DNA microarray gene 
expression data. It utilizes null space of covariance matrix for feature selection. The algorithm can perform bulk reduction 
of features (genes) while maintaining the quality information in the reduced subset of features for discriminative purpose. 
Thus, it can be used as a pre-processing step for other feature selection algorithms. The algorithm does not assume 
statistical independency among the features. The algorithm shows promising classification accuracy when compared with 
other existing techniques on several DNA microarray gene expression datasets.  
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INTRODUCTION 
 The advent of microarray technology has enabled the 
researchers to rapidly measure the expression levels of 
thousands of genes in a biological tissue sample in a single 
experiment [1]. One important application of this microarray 
technology is to classify the tissue samples, especially cancer 
cells, using their gene expression profiles as one of the 
several classes (or subclasses). Compared with the standard 
histopathological tests in cancer diagnosis, the gene 
expression profiles measured through microarray technology 
provide accurate, reliable and objective cancer classification; 
it is possible to uncover cancer subclasses that are related 
with the efficacy of anti-cancer drugs that are hard to be 
predicted by pathological tests. The study of identification of 
genes characterizing heterogeneity of human cancers plays 
crucial role in modern day bio-medical sciences.  
 The microarray gene expression data for cancer 
classification consists of large number of genes (dimensions) 
compared to the number of samples to be classified. Not all 
the features contribute affirmatively to a given task. In fact 
in some cases it degrades the generalization performance of 
the classifier and increases its computational complexity. If 
the dimensionality of feature vectors is very large then the 
selection of features is not reachable in a reasonable amount 
of time even using high performance computers. Therefore, 
it is essential to discard non informative features for a given 
task in a reasonable amount of time. In order to identify 
informative genes, several feature selection algorithms have 
been proposed in the literature [2]-[12]. These algorithms 
can be broadly classified in to two main categories namely 
filter based methods and wrapper based methods[13]. The  
filter based methods are computationally faster and are 
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independent of the classifiers. On the other hand, the 
wrapper based methods are computationally intensive and 
are dependent on classifiers. Most of these feature selection 
algorithms investigate the importance of individual features 
in conjunction with the information attained from the 
combination of other features. The principal component 
analysis (PCA) technique which is a popular dimensionality 
reduction technique is also used for feature selection of gene 
expression data [14], [15]. In the PCA technique, the range 
space information of covariance matrix is utilized for feature 
selection. The null space of covariance matrix is discarded. 
Although, the null space of covariance matrix (or total 
scatter matrix) contains no discriminative information and 
has been discarded in the discriminant techniques [16] and 
PCA technique [14], [15], we utilize the null space of 
covariance matrix for gene selection and show that it can 
help in discarding non-informative features. The objective is 
to develop a filter based feature selection algorithm that can 
provide high classification performance on DNA microarray 
gene expression datasets. The proposed feature selection 
algorithm associates some scoring to the individual genes. 
The genes with the lowest scores are to be discarded. The 
algorithm is computationally efficient; i.e., its computational 
complexity is  (where  is the dimension of feature 
vectors and  is the number of samples). The algorithm 
identifies weak or low important genes and therefore it can 
be used as a pre-processing step for other feature selection 
algorithms. The algorithm does not assume statistical 
independencies among the features as assumed in naïve 
Bayes’ classifiers [17].  
PROPOSED GENE SELECTION ALGORITHM 
 In this work we utilize the null space of covariance 
matrix to select genes which is discarded in discriminant 
techniques [16] and PCA technique [14], [15]. In this 
section, we show that it can still be utilized to discard non-
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informative genes which would help in the classification 
task. In order to define the algorithm, we first denote the 
notations used. Let 
 
be a set of n training 
vectors in a d-dimensional feature space. Let μ
 
be the 
centroid ofand  A be the rectangular matrix defined as 
         (1) 
 The covariance of can be given by 
           (2) 
 Let the rank of  or  be . The singular value 
decomposition (SVD) procedure on matrix can be used to 
compute eigenvalues and eigenvectors of , this will give 
            (3) 
Let , where orthogonal matrix 
 
corresponds to the range space of 
 
and orthogonal matrix 
 corresponds to the null space of . Let 
 be any vector in then 
           (4) 
 In practice the vector  can be economically obtained by 
performing Gram-Schmidt orthogonalization procedure on 
the  column vectors of to get the th basis vector. 
It can be observed from equation 4 that the variance of 
feature vectors in the null space is zero. Therefore, the 
projected feature vectors on the null space can be given by 
, where          (5) 
 If we define ,  and  as features of ,  and  
respectively then we can write equation 5 as 
          (6) 
 Let  and if 
 
is arranged in 
descending order such that 
  
then -th feature can be discarded for which  as it is 
not providing any significant contribution in making the 
summation zero (in equation 6). The value of  which is 
close to zero, imply that  th gene is non-informative or has 
little information and shall be discarded. An illustration is 
given in Figure 1, which shows the curve of  as a 
function of  . 
 In the figure the bottom  features are discarded for 
which their values are small. The optimum value of  
can be determined by applying cross-validation procedure. 
We can also roughly determine the value of  by taking the 
argument of median of , this will retain approximately 
50% of the features. In the experiment section we will show 
that the reduction of more than 50% of features can be 
achieved without any degradation in the performance (in 
terms of classification accuracy) on a number of gene 
expression datasets. The algorithm is summarized in Table 1. 
Since the algorithm requires an ortho normal vector in the 
null space of covariance matrix, the computation of range 
space ortho normal vectors is required. Therefore, the 
computational complexity of the algorithm is . 
Table 1. Feature selection algorithm. 
Step 1. Compute matrix  from equation 1. 
Step 2. Find orthogonormal vector  that corresponds to the 
null space of . 
Step 3. Compute  and arrange  in 
descending order. 
Step 4. Select the top  features. 
EXPERIMENTATION 
 In order to verify the performance of the proposed feature 
selection algorithm, we use four DNA microarray gene 
expression datasets. The description of these datasets is 
given as follows: 
1 10 20 ..... ..... ..... d
0
k
 
Fig. (1). Curve of  as a function of   to discard bottom  features. 
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 Acute Leukemia dataset [18]: this dataset consists of 
DNA microarray gene expression data of human acute 
leukemias for cancer classification. Two types of acute 
leukemias data are provided for classification namely acute 
lymphoblastic leukemia (ALL) and acute myeloid leukemia 
(AML). The dataset is subdivided into 38 training samples 
and 34 test samples. The training set consists of 38 bone 
marrow samples (27 ALL and 11 AML) over 7129 probes. 
The test set consists of 34 samples with 20 ALL and 14 
AML, prepared under different experimental conditions. All 
the samples have 7129 dimensions and all are numeric. 
 SRBCT dataset [19]: the small round blue-cell tumor 
dataset consists of 83 samples with each having 2308 genes. 
This is a four class classification problem. The tumors are 
Burkitt lymphoma (BL), the Ewing family of tumors (EWS), 
neuroblastoma (NB) and rhabdomyosarcoma (RMS). There 
are 63 samples for training and 20 samples for testing. The 
training set consists of 8, 23, 12 and 20 samples of BL, 
EWS, NB and RMS respectively. The test set consists of 3, 
6, 6 and 5 samples of BL, EWS, NB and RMS respectively. 
 MLL Leukemia dataset [20]: this dataset has 3 classes 
namely ALL, MLL and AML leukemia. The training set 
contains 57 leukemia samples (20 ALL, 17 MLL and 20 
AML) whereas the test set contains 15 samples (4 ALL, 3 
MLL and 8 AML). The dimension of MLL dataset is 12582. 
 Lung Dataset [21]: this dataset contains gene expression 
levels of malignantmesothelioma (MPM) and 
adenocarcinoma (ADCA) of the lung. There are 181 tissue 
samples (31 MPM and 150 ADCA). The training set 
contains 32 of them, 16 MPM and 16 ADCA. The rest of 
149 samples are used for testing. Each sample is described 
by 12533 genes. 
 In this experiment, first we measure the performance (in 
terms of classification accuracy) without reducing the 
features. Then we reduce the feature numbers using the 
proposed feature selection algorithm. In the three set of 
experiments we retain 50%, 25% and 13% of features and 
evaluate their performance. The null LDA algorithm[22]with 
nearest neighbor classifier is used as a classifier. Table 2 
shows the performance of the proposed algorithm. 
 It can be observed from Table 2 that the classification 
accuracy obtained by the classifier on original featuresize 
and the selected feature set is the same. This shows that the 
proposed algorithm is capable of removing a major portion 
of unimportant features. Once the feature size is reduced 
then other feature selection algorithms can be used to obtain 
important features further. In order to demonstrate this, we 
utilize support vector machine (SVM) for feature selection 
and Random Forest (RF) for classification from Weka 
environment [23]. First we select 100 features using SVM 
from the original feature space and then apply RF classifier 
to evaluate the classification accuracy on each of the 
datasets. Next, we apply the filter based methods to reduce 
features to 13% of the original feature size. From this subset 
we select 100 features by applying SVM and then RF is used 
to measure the classification accuracy. The following filter 
based methods are used for comparison: Chi-Squared, Gain 
Ratio, Info Gain, t-Statistics and OneR. The comparison is 
depicted in Table 3. 
 It can be observed from Table 3 that the classification 
accuracy obtained by the proposed algorithm is competent 
with other algorithms. In comparison with SVM algorithm 
(which was conducted on the original feature space) it can be 
seen that the classification accuracy of the proposed 
algorithm was either same (for SRBCT and MLL Leukemia) 
or improved (for Acute Leukemia and Lung Cancer); i.e., it 
discards the unimportant genes which are deteriorating or not 
helping in the classification task. 
 To analyze the difference of filter based methods (used in 
Table 3) in terms of the number of common genes, we utilize 
Lung Cancer dataset as a prototype and apply the selected 
100 genes (which were used to obtain the classification 
accuracy of Lung Cancer data in Table 3). The number of 
common genes among the filter based methods is depicted in 
Table 4. The higher value of common genes in Table 4 
implies similarity between the compared two algorithms. For 
an instance, the number of genes selected by Chi-Squared is 
very much similar to Gain Ratio and Info Gain algorithms. It 
can also be seen that t-Statistics and the proposed algorithm 
produce quite different genes. Therefore, they are dissimilar 
compared to other filter based methods used. This shows that 
Table 2. Performance in terms of classification accuracy on the original feature set and on the selected feature set using the 
proposed algorithm. Classification accuracies are depicted in percentage and the number of features selected is shown in 
parenthesis. 
Dataset All Features 
(no Reduction) 
Using 50% Features Using 25% Features Using 13% Features 
SRBCT 100% 
(k = 2308) 
100% 
(k = 1154) 
100% 
(k = 577) 
100% 
(k = 300) 
Acute Leukemia 97.06% 
 
97.06% 
 
97.06% 
K 
97.06% 
 
MLL Leukemia 100% 
 
100% 
 
100% 
 
100% 
 
Lung Cancer 97.99% 
 
97.99% 
 
97.99% 
 
97.99% 
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the proposed algorithm can be applied with other feature 
selection methods to extract more information. 
 In the next part of the experiment, we explore the 
biological significance of the selected features from the 
proposed algorithm. In order to find the biological 
significance, we analyze the functional properties of the 
selected features using Ingenuity Pathway Analysis (IPA, 
http://www.Ingenuity.com). We use MLL Leukemia data as 
a prototype for this purpose. In this case, first 13% features 
are selected using the proposed algorithm and then IPA 
system is used to find its functional properties. Several 
significant high-level biological functions are obtained using 
the selected features. The top 5 high-level functions are 
depicted in Figure 2. The y-axis shows the negative 
logarithm of -values and x-axis shows the biological 
functions. The biological function of interest is cancer; under 
this function 120 significant cancer functions are obtained. 
Some of the selected cancer functions with their 
corresponding -values are summarized in Table 5. It can be 
seen from Table 5 that significant biological functions can be 
identified using the selected features from the proposed 
algorithm.  
 It can be concluded from the experiments that the 
proposed algorithm discards several unimportant features 
and retains useful features. 
 
Fig. (2). Top 5 high-level biological functions using the selected 
features by the proposed algorithm on MLL Leukemia dataset. 
CONCLUSION 
 A new filter based feature selection algorithm for DNA 
microarray gene expression data has been proposed which 
discards unimportant features from the large set of features. 
The proposed algorithm utilizes null space of covariance 
matrix to discard unimportant features. It does not assume 
the independency among the features. It is observed in the 
experiments that the algorithm efficiently reduces major 
portion of features without degrading the classification 
performance for several DNA microarray gene expression 
datasets. The comparison with other filter based methods 
shows promising results. 
Table 3. Comparison using classification accuracy on various algorithms. 
 
Algorithm Acute LEUKEMIA 
(Classification 
Accuracy) 
SRBCT 
(Classification 
Accuracy) 
MLL Leukemia 
(Classification 
Accuracy) 
Lung Cancer 
(Classification 
Accuracy) 
SVM + RF 88.24% 95.00% 100.00% 95.97% 
Chi-Squared + SVM + RF 76.47% 80.00% 100.00% 96.64% 
GainRatio + SVM + RF 76.47% 95.00% 100.00% 98.66% 
InfoGain + SVM + RF 94.12% 90.00% 100.00% 94.63% 
t-Statistics + SVM + RF 85.29% 70.00% 100.00% 95.30% 
OneR + SVM + RF 88.24% 95.00% 86.67% 93.96% 
Proposed algorithm + SVM+RF 97.06% 95.00% 100.00% 97.32% 
Table 4: Common genes in different algorithms 
 
Algorithms Chi-Squared Gain Ratio Info Gain OneR t-Statistics Proposed alg. 
Chi-Squared X 93 93 86 50 49 
Gain Ratio 93 X 90 87 48 47 
Info Gain 93 90 X 84 49 48 
OneR 86 87 84 X 50 48 
t-Statistics 50 48 49 50 X 39 
Proposed alg. 49 47 48 48 39 X 
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